Stock Events

Stock Events

VYNE Therapeutics (VYNE) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.3

-0.25

-0.19

-0.13

Details

Expected EPS

-0.223333

Actual EPS

-0.13

Surprise EPS

0.09

Surprise Percent

+41.79%

Description

VYNE Therapeutics (VYNE) has reported earnings of -0.13 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.